Diagnostic Accuracy of Cross-Polarization OCT and OCT-Elastography for Differentiation of Breast Cancer Subtypes: Comparative Study
- PMID: 33255263
- PMCID: PMC7760404
- DOI: 10.3390/diagnostics10120994
Diagnostic Accuracy of Cross-Polarization OCT and OCT-Elastography for Differentiation of Breast Cancer Subtypes: Comparative Study
Abstract
The possibility to assess molecular-biological and morphological features of particular breast cancer types can improve the precision of resection margin detection and enable accurate determining of the tumor aggressiveness, which is important for treatment selection. To enable reliable differentiation of breast-cancer subtypes and evaluation of resection margin, without performing conventional histological procedures, here we apply cross-polarization optical coherence tomography (CP-OCT) and compare it with a novel variant of compressional optical coherence elastography (C-OCE) in terms of the diagnostic accuracy (Ac) with histological verification. The study used 70 excised breast cancer specimens with different morphological structure and molecular status (Luminal A, Luminal B, Her2/Neo+, non-luminal and triple-negative cancer). Our first aim was to formulate convenient criteria of visual assessment of CP-OCT and C-OCE images intended (i) to differentiate tumorous and non-tumorous tissues and (ii) to enable more precise differentiation among different malignant states. We identified such criteria based on the presence of heterogeneities and characteristics of signal attenuation in CP-OCT images, as well as the presence of inclusions/mosaic structures combined with visually feasible assessment of several stiffness grades in C-OCE images. Secondly, we performed a blinded reader study of the Ac of C-OCE versus CP-OCT, for delineation of tumorous versus non-tumorous tissues followed by identification of breast cancer subtypes. For tumor detection, C-OCE showed higher specificity than CP-OCT (97.5% versus 93.3%) and higher Ac (96.0 versus 92.4%). For the first time, the Ac of C-OCE and CP-OCT were evaluated for differentiation between non-invasive and invasive breast cancer (90.4% and 82.5%, respectively). Furthermore, for invasive cancers, the difference between invasive but low-aggressive and highly-aggressive subtypes can be detected. For differentiation between non-tumorous tissue and low-aggressive breast-cancer subtypes, Ac was 95.7% for C-OCE and 88.1% for CP-OCT. For differentiation between non-tumorous tissue and highly-aggressive breast cancers, Ac was found to be 98.3% for C-OCE and 97.2% for CP-OCT. In all cases C-OCE showed better diagnostic parameters independently of the tumor type. These findings confirm the high potential of OCT-based examinations for rapid and accurate diagnostics during breast conservation surgery.
Keywords: breast cancer; compressional optical coherence elastography (C-OCE); cross-polarization optical coherence tomography (CP-OCT); image assessment.
Conflict of interest statement
The authors declare no conflict of interest. The funders/sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures





Similar articles
-
Intraoperative Assessment of Breast Cancer Tissues after Breast-Conserving Surgery Based on Mapping the Attenuation Coefficients in 3D Cross-Polarization Optical Coherence Tomography.Cancers (Basel). 2023 May 8;15(9):2663. doi: 10.3390/cancers15092663. Cancers (Basel). 2023. PMID: 37174128 Free PMC article.
-
Cross-Polarization Optical Coherence Tomography for Brain Tumor Imaging.Front Oncol. 2019 Apr 2;9:201. doi: 10.3389/fonc.2019.00201. eCollection 2019. Front Oncol. 2019. PMID: 31001471 Free PMC article.
-
OCT-elastography-based optical biopsy for breast cancer delineation and express assessment of morphological/molecular subtypes.Biomed Opt Express. 2019 Apr 4;10(5):2244-2263. doi: 10.1364/BOE.10.002244. eCollection 2019 May 1. Biomed Opt Express. 2019. PMID: 31143491 Free PMC article.
-
Optical coherence elastography in ophthalmology.J Biomed Opt. 2017 Dec;22(12):1-28. doi: 10.1117/1.JBO.22.12.121720. J Biomed Opt. 2017. PMID: 29275544 Free PMC article. Review.
-
Optical coherence elastography: current status and future applications.J Biomed Opt. 2011 Apr;16(4):043001. doi: 10.1117/1.3560294. J Biomed Opt. 2011. PMID: 21529067 Review.
Cited by
-
OCT in Oncology and Precision Medicine: From Nanoparticles to Advanced Technologies and AI.Bioengineering (Basel). 2025 Jun 13;12(6):650. doi: 10.3390/bioengineering12060650. Bioengineering (Basel). 2025. PMID: 40564467 Free PMC article. Review.
-
Recent advances in optical elastography and emerging opportunities in the basic sciences and translational medicine [Invited].Biomed Opt Express. 2022 Dec 16;14(1):208-248. doi: 10.1364/BOE.468932. eCollection 2023 Jan 1. Biomed Opt Express. 2022. PMID: 36698669 Free PMC article. Review.
-
Nonlinear Elasticity Assessment with Optical Coherence Elastography for High-Selectivity Differentiation of Breast Cancer Tissues.Materials (Basel). 2022 May 5;15(9):3308. doi: 10.3390/ma15093308. Materials (Basel). 2022. PMID: 35591642 Free PMC article.
-
Prediction of disease-free survival using strain elastography and diffuse optical tomography in patients with T1 breast cancer: a 10-year follow-up study.BMC Cancer. 2024 Aug 27;24(1):1057. doi: 10.1186/s12885-024-12844-z. BMC Cancer. 2024. PMID: 39192199 Free PMC article.
-
Wave-based optical coherence elastography: The 10-year perspective.Prog Biomed Eng (Bristol). 2022 Jan;4(1):012007. doi: 10.1088/2516-1091/ac4512. Epub 2022 Jan 14. Prog Biomed Eng (Bristol). 2022. PMID: 35187403 Free PMC article.
References
-
- Decker M.R., Trentham-Dietz A., Loconte N.K., Neuman H.B., Smith M.A., Punglia R.S., Greenberg C.C., Wilke L.G. The Role of Intraoperative Pathologic Assessment in the Surgical Management of Ductal Carcinoma In Situ. Ann. Surg. Oncol. 2016;23:2788–2794. doi: 10.1245/s10434-016-5192-5. - DOI - PMC - PubMed
-
- Lamberts L.E., Koch M., de Jong J.S., Adams A.L.L., Glatz J., Kranendonk M.E.G., van Scheltinga A.G.T.T., Jansen L., de Vries J., Lub-de Hooge M.N., et al. Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study. Clin. Cancer Res. 2017;23:2730–2741. doi: 10.1158/1078-0432.CCR-16-0437. - DOI - PubMed
-
- Tummers Q.R., Verbeek F.P., Schaafsma B.E., Boonstra M.C., van der Vorst J.R., Liefers G.J., van de Velde C.J., Frangioni J.V., Vahrmeijer A.L. Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and Methylene Blue. Eur. J. Surg. Oncol. 2014;40:850–858. doi: 10.1016/j.ejso.2014.02.225. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous